A case of acute renal failure with marked hyperuricemia developing during mizoribine administration

Japanese Journal of Nephrology

Volumn 44, Issue 7, 2002, Pages 543-546

  Kushihata, Shigeyuki ^a   Hirabayashi, Akira ^d   Sekiguchi, Yoshitaka ^d   Nagai, Kenichi ^b   Arata, Toshihiko ^c  

^a JA Hiroshima General Hospital at Jigozen   (Japan)

^b Kushido Eiwa Clinic Nanao bunninn   (Japan)

^c Ohtake Chuou Clinic   (Japan)

^d NONE

Author keywords

Acute renal failure; Hyperuricemia; Mizoribine

Indexed keywords

ALLOPURINOL; GALLIUM; MIZORIBINE;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BLOOD CULTURE; CASE REPORT; CHURG STRAUSS SYNDROME; DISEASE SEVERITY; HEMODIALYSIS; HUMAN; HYPERURICEMIA; KIDNEY FUNCTION; MALE; SCINTIGRAPHY; STEROID THERAPY;

ALLOPURINOL; CHURG-STRAUSS SYNDROME; HUMANS; HYPERURICEMIA; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; RENAL DIALYSIS; RIBONUCLEOSIDES; TREATMENT OUTCOME;

EID: 0036438502     PISSN: 03852385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sakaguti K, Tujino M, Kawai K, Mzuno K, Hayano K. Mode of action of bredinin with guanylic acid on L5178y mouse leukemia cell. J Antibiot 1976; 29: 1320-9.
2. Kusumi T, Tuda M, Katunuma T, Yamaura M. Dual inhibitory effect of bredinin. Cell Biochem Func 1988; 7: 201-4.
3. Takeda K, Yosikawa H, Muranishi S, Takahara S, Ichikawa Y. Elimination characteristics of bredinin from patients serum in hemodialysis. Int J Clin Pharmacol Ther Toxicol 1985; 23: 197-9.